Osteoarthritis, KneeATKOSNCT04247672
The ATtune Knee Outcome Study
An observational study of Osteoarthritis, Knee and Knee Osteoarthritis, run by Spaarne Gasthuis at 1 site in Netherlands.
Trial summary
To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. Read more about this study
- Who is it for?
- Ages 21 to 90 years
- Conditions the study is for
- Osteoarthritis, Knee, Knee Osteoarthritis, Knee Rheumatism
- What is being tested?
- Total Knee Arthroplasty (uncemented rotating platform ATTUNE)
- Type of treatment
- Medical device
- How many people
- 900 participants
- Where
- 1 siteNetherlands
- Study dates
- 3 Feb 2020to 22 Jan 2036
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 90 years
- All sexes
- Adult, Older adult
Study population: All patients with end-stage knee disease (e.g. knee osteoarthritis) warranting and able to undergo knee replacement therapy.
Who may be able to join
- End-stage osteoarthritis of the knee warranting joint replacement therapy.
- Indicated for an ATTUNE total knee system as part of regular clinical practice.
- Capability and willingness to sign informed consent and comply with follow-up procedures.
- Capable enough in Dutch or English to be able to understand study procedures
Who cannot join
- Unable or unwilling to sign informed consent and comply with follow-up
- Indication for primary revision arthroplasty
- Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Netherlands1 site, 1 recruiting
- Recruiting
Spaarne Gasthuis
Hoofddorp, North Holland, 2134 TM
Marjolein Schager, Registered Nurse, 023 22 41673, mschager@spaarnegasthuis.nl
Peter A Nolte, Orthopedic Surgeon
About this study
Official title: The ATtune Knee Outcome Study: Prospective Evaluation of a Novel Uncemented Rotating Platform Total Knee Arthroplasty
To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.
Read the detailed description
Every year, 1.5 million total knee arthroplasties (TKA) are performed worldwide in patients whose joints have been severely affected by osteoarthritis, rheumatoid arthritis, or trauma, causing intense pain and loss of function. Due to the ageing society, these numbers are expected to have increased six-fold to 3.48 million cases annually by 2030. Even though joint replacement provides satisfactory and durable results for most patients, 20% is thought to still not be satisfied with their artificial joint. To accommodate this dissatisfied population and improve durability of implants even more, several knee systems have been developed over the years. One of the newest models is the ATTUNE knee system (DePuy, Warsaw, Indiana, USA). One of the landmark features is a gradually reducing radius in the geometry of the femoral component, more closely mimicking the anatomical patellofemoral joint and facilitating more natural femoral rollback during flexion. Comparisons of the cemented ATTUNE with previous knee systems show promising results in terms of patellofemoral outcomes, but fail to demonstrate definitive superiority in terms of all patient reported outcomes. Clinical superiority of the ATTUNE tends to abate with longer follow-up, implicating a possible superiority in the short-term recovery and return to activities. There is no follow-up study reporting the results of the uncemented ATTUNE. Moreover, all previously cited studies report better patellofemoral outcomes with patellar resurfacing, making it still unclear whether the implicated superior design changes of the femoral component hold ground without patellar resurfacing.
The primary objective is to report survivorship, complications and patient reported outcome measures associated with the uncemented ATTUNE rotating platform knee system. Secondary objectives are (1) evaluate patient reported (patellofemoral) outcomes (2) assess return to work and sport after TKA (3) translate and validate the Dutch version of the University of California, Los Angeles (UCLA) activity scale and (4) analyse psychologic factors (such as pain catastrophising and coping) and the impact on dissatisfaction following TKA.
- Being tested
- Total Knee Arthroplasty (uncemented rotating platform ATTUNE)
- Medical subject headings
- Osteoarthritis, Knee, Arthritis, Rheumatoid
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Total Knee Arthroplasty (uncemented rotating platform ATTUNE)Device
Also called Total knee arthroplasty
All patients receive an uncemented ATTUNE rotating platform knee system.
What is being measured
The primary outcome is the main question the study is designed to answer.
Survivorship
Calculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately.
Measured: 10 year
Complication rate
All substantial complications associated with total knee arthroplasty will be registered and reported
Measured: 10 year
Forgotten Joint Score 12 (FJS-12)
Measured: 10 year
Kujala Anterior Knee Pain Scale (AKPS)
Measured: 10 year
Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form
KOOS-PS
Measured: 10 year
Numeric Rating Scale (NRS)
NRS on pain and satisfaction
Measured: 10 year
EuroQol 5 Dimensions, 3 Levels (EQ5D-3L)
Measured: 10 year
Secondary outcomes (10)
30 second chair stand test (30sCST)
The amount of times one can stand up and sit down from a chair in 30 seconds
Measured: 1 year
40m Fast paced walk test (40m-FPWT)
The amount of seconds one does to walk 40 meters.
Measured: 1 year
Stair climb test (SCT)
The time one takes to walk a set of stairs up and down.
Measured: 1 year
Tegner activity rating scale
1-item questionnaire
Measured: 1 year
University of California, Los Angeles (UCLA) activity rating scale
1-item questionnaire
Measured: 1 year
Return to work
Assessed by a short self-composed questionnaire, which evaluates what kind of work the patients do, when they started after surgery and whether this is the same as their preoperative job
Measured: 1 year
Alignment
A long-leg radiograph is performed 1 year after surgery to assess mechanical alignment of the prosthesis with consideration of femur and tibia
Measured: 1 year
Patient Health Questionnaire (PHQ-2)
2-item questionnaire to screen for major depressive episodes
Measured: 10 year
Pain Self Efficacy Questionnaire (PSEQ)
Questionnaire to asses pain self efficacy
Measured: 10 year
Pain Catastrophizing Scale (PCS)
Explores pain catastrophizing and its relation to pain behaviour
Measured: 10 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jan 2020
- Study start3 Feb 2020
- Primary completion22 Jan 2024 (estimated)
- Study completion22 Jan 2036 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Osteoarthritis, KneeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 900 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Spaarne Gasthuis
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04247672
- Sponsor's protocol ID
- 2019.0084
- Acronym
- ATKOS
- Status last verified
- Apr 2022
- First submitted
- 20 Jan 2020
- Last updated
- 27 Apr 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- Yes
- Individual data sharing
- No
Publications
Rassir R, Sierevelt IN, Schager M, Nolte PA; ATKOS group. Design and rationale of the ATtune Knee Outcome Study (ATKOS): multicenter prospective evaluation of a novel uncemented rotating platform knee system. BMC Musculoskelet Disord. 2021 Jul 15;22(1):622. doi: 10.1186/s12891-021-04493-1.
PubMed 34266444
Study at a glance
From the registry record, last updated by the sponsor on 27 Apr 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The ATtune Knee Outcome Study: Prospective Evaluation of a Novel Uncemented Rotating Platform Total Knee Arthroplasty
- ClinicalTrials.gov ID
- NCT04247672
- Acronym / sponsor ID
- ATKOS / 2019.0084
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 900 participants (estimated)
- Lead sponsor
- Spaarne GasthuisUniversity, hospital or other
- Study start
- 3 Feb 2020 (actual)
- Primary completion
- 22 Jan 2024 (estimated)
- Study completion
- 22 Jan 2036 (estimated)
- First posted
- 30 Jan 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To accomodate dissatisfied patients with a total knee arthroplasty (TKA) and improve outcomes, several knee systems have been developed. The cemented ATTUNE TKA shows superiority over other established knee systems at short-term, abating with longer follow-up. There have been no studies reporting on the results of the uncemented version of the ATTUNE. Therefore, the main objective of the current study was to report patient reported outcome measures (PROMs), survivorship and complications associated with the uncemented ATTUNE TKA.
Detailed description
Every year, 1.5 million total knee arthroplasties (TKA) are performed worldwide in patients whose joints have been severely affected by osteoarthritis, rheumatoid arthritis, or trauma, causing intense pain and loss of function. Due to the ageing society, these numbers are expected to have increased six-fold to 3.48 million cases annually by 2030. Even though joint replacement provides satisfactory and durable results for most patients, 20% is thought to still not be satisfied with their artificial joint. To accommodate this dissatisfied population and improve durability of implants even more, several knee systems have been developed over the years. One of the newest models is the ATTUNE knee system (DePuy, Warsaw, Indiana, USA). One of the landmark features is a gradually reducing radius in the geometry of the femoral component, more closely mimicking the anatomical patellofemoral joint and facilitating more natural femoral rollback during flexion. Comparisons of the cemented ATTUNE with previous knee systems show promising results in terms of patellofemoral outcomes, but fail to demonstrate definitive superiority in terms of all patient reported outcomes. Clinical superiority of the ATTUNE tends to abate with longer follow-up, implicating a possible superiority in the short-term recovery and return to activities. There is no follow-up study reporting the results of the uncemented ATTUNE. Moreover, all previously cited studies report better patellofemoral outcomes with patellar resurfacing, making it still unclear whether the implicated superior design changes of the femoral component hold ground without patellar resurfacing.
The primary objective is to report survivorship, complications and patient reported outcome measures associated with the uncemented ATTUNE rotating platform knee system. Secondary objectives are (1) evaluate patient reported (patellofemoral) outcomes (2) assess return to work and sport after TKA (3) translate and validate the Dutch version of the University of California, Los Angeles (UCLA) activity scale and (4) analyse psychologic factors (such as pain catastrophising and coping) and the impact on dissatisfaction following TKA.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 21 to 90 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- All patients with end-stage knee disease (e.g. knee osteoarthritis) warranting and able to undergo knee replacement therapy.
Key inclusion criteria (4 listed)
- End-stage osteoarthritis of the knee warranting joint replacement therapy.
- Indicated for an ATTUNE total knee system as part of regular clinical practice.
- Capability and willingness to sign informed consent and comply with follow-up procedures.
- Capable enough in Dutch or English to be able to understand study procedures
Key exclusion criteria (3 listed)
- Unable or unwilling to sign informed consent and comply with follow-up
- Indication for primary revision arthroplasty
- Absolute indication for cemented fixation (decreased bone stock/quality of spongiosa)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Total Knee Arthroplasty (uncemented rotating platform ATTUNE)Also: Total knee arthroplastyAll patients receive an uncemented ATTUNE rotating platform knee system. | Device | – |
Primary outcome
Survivorship
Time frame: 10 year
Calculated by determining revision rate. Septic, aseptic and all-cause revision rates will be calculated seperately.
Complication rate
Time frame: 10 year
All substantial complications associated with total knee arthroplasty will be registered and reported
Forgotten Joint Score 12 (FJS-12)
Time frame: 10 year
Kujala Anterior Knee Pain Scale (AKPS)
Time frame: 10 year
Knee injury and Osteoarthritis Outcome Scale - Physical Function Short Form
Time frame: 10 year
KOOS-PS
Numeric Rating Scale (NRS)
Time frame: 10 year
NRS on pain and satisfaction
EuroQol 5 Dimensions, 3 Levels (EQ5D-3L)
Time frame: 10 year
10 secondary outcomes
30 second chair stand test (30sCST)
Time frame: 1 year
40m Fast paced walk test (40m-FPWT)
Time frame: 1 year
Stair climb test (SCT)
Time frame: 1 year
Tegner activity rating scale
Time frame: 1 year
University of California, Los Angeles (UCLA) activity rating scale
Time frame: 1 year
Return to work
Time frame: 1 year
Alignment
Time frame: 1 year
Patient Health Questionnaire (PHQ-2)
Time frame: 10 year
Pain Self Efficacy Questionnaire (PSEQ)
Time frame: 10 year
Pain Catastrophizing Scale (PCS)
Time frame: 10 year
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 Apr 2022.
- Derived from this study: PubMed 34266444Rassir R, Sierevelt IN, Schager M, Nolte PA; ATKOS group. Design and rationale of the ATtune Knee Outcome Study (ATKOS): multicenter prospective evaluation of a novel uncemented rotating platform knee system. BMC Musculoskelet Disord. 2021 Jul 15;22(1):622. doi: 10.1186/s12891-021-04493-1.
- Individual participant dataSharing planned: No
Related trials for Osteoarthritis, Knee
Recruiting
Outpatient Physiotherapy vs. mHealth Exercise and Self-Management for Knee Osteoarthritis (MOKneeTOR)
Knee Osteoarthristis
Not yet recruiting
Effects of Music During Walking on Pain and Muscle Activation in People With Chronic Pain Due to Knee Osteoarthritis
Knee Osteoarthritis
Recruiting
Radio- KO Radiotherapy for Knee Osteoarthritis Clinical Trial
Osteoarthritis, Knee
Not yet recruiting
Opioid Reduction and Enhanced Recovery in Orthopaedic Surgery (OREOS)-Knee
Knee Arthroplasty, Total, Partial Knee Arthroplasty
Not yet recruiting
Effects of Low-Load Blood Flow Restriction Resistance Training With and Without Hip Abductor Strengthening in Patients With Knee Osteoarthritis.(BFR)
Knee Osteoarthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Osteoarthritis, Knee and Knee Osteoarthritis, run by Spaarne Gasthuis at 1 site in Netherlands.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 27 Apr 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Survivorship (time frame: 10 year). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04247672, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Apr 2022.